Literature DB >> 27909266

Reliability of infarct volumetry: Its relevance and the improvement by a software-assisted approach.

Felix Friedländer1, Ferdinand Bohmann1, Max Brunkhorst1, Ju-Hee Chae1, Kavi Devraj1, Yvette Köhler2, Peter Kraft3, Hannah Kuhn1, Alexandra Lucaciu1, Sebastian Luger1, Waltraud Pfeilschifter1, Rebecca Sadler4, Arthur Liesz4,5, Karolina Scholtyschik3, Leonie Stolz1, Rajkumar Vutukuri1,2, Robert Brunkhorst1,2.   

Abstract

Despite the efficacy of neuroprotective approaches in animal models of stroke, their translation has so far failed from bench to bedside. One reason is presumed to be a low quality of preclinical study design, leading to bias and a low a priori power. In this study, we propose that the key read-out of experimental stroke studies, the volume of the ischemic damage as commonly measured by free-handed planimetry of TTC-stained brain sections, is subject to an unrecognized low inter-rater and test-retest reliability with strong implications for statistical power and bias. As an alternative approach, we suggest a simple, open-source, software-assisted method, taking advantage of automatic-thresholding techniques. The validity and the improvement of reliability by an automated method to tMCAO infarct volumetry are demonstrated. In addition, we show the probable consequences of increased reliability for precision, p-values, effect inflation, and power calculation, exemplified by a systematic analysis of experimental stroke studies published in the year 2015. Our study reveals an underappreciated quality problem in translational stroke research and suggests that software-assisted infarct volumetry might help to improve reproducibility and therefore the robustness of bench to bedside translation.

Entities:  

Keywords:  Neuroprotection; experimental stroke; image analysis; middle cerebral artery occlusion; power

Mesh:

Year:  2016        PMID: 27909266      PMCID: PMC5536806          DOI: 10.1177/0271678X16681311

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.

Authors:  Matthias J Müller; Armin Szegedi
Journal:  J Clin Psychopharmacol       Date:  2002-06       Impact factor: 3.153

Review 2.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

Review 3.  Improving outcome after stroke: overcoming the translational roadblock.

Authors:  Matthias Endres; Britta Engelhardt; Jari Koistinaho; Olle Lindvall; Stephen Meairs; Jay P Mohr; Anna Planas; Nancy Rothwell; Markus Schwaninger; Martin E Schwab; Denis Vivien; Tadeusz Wieloch; Ulrich Dirnagl
Journal:  Cerebrovasc Dis       Date:  2008-02-22       Impact factor: 2.762

4.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.

Authors:  Gemma Llovera; Kerstin Hofmann; Stefan Roth; Angelica Salas-Pérdomo; Maura Ferrer-Ferrer; Carlo Perego; Elisa R Zanier; Uta Mamrak; Andre Rex; Hélène Party; Véronique Agin; Claudine Fauchon; Cyrille Orset; Benoît Haelewyn; Maria-Grazia De Simoni; Ulrich Dirnagl; Ulrike Grittner; Anna M Planas; Nikolaus Plesnila; Denis Vivien; Arthur Liesz
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

5.  Meta-analysis of data from animal studies: a practical guide.

Authors:  H M Vesterinen; E S Sena; K J Egan; T C Hirst; L Churolov; G L Currie; A Antonic; D W Howells; M R Macleod
Journal:  J Neurosci Methods       Date:  2013-10-04       Impact factor: 2.390

6.  A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation.

Authors:  Pamela W M Kleikers; Carlijn Hooijmans; Eva Göb; Friederike Langhauser; Sarah S J Rewell; Kim Radermacher; Merel Ritskes-Hoitinga; David W Howells; Christoph Kleinschnitz; Harald H H W Schmidt
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

7.  Risk of Bias in Reports of In Vivo Research: A Focus for Improvement.

Authors:  Malcolm R Macleod; Aaron Lawson McLean; Aikaterini Kyriakopoulou; Stylianos Serghiou; Arno de Wilde; Nicki Sherratt; Theo Hirst; Rachel Hemblade; Zsanett Bahor; Cristina Nunes-Fonseca; Aparna Potluru; Andrew Thomson; Julija Baginskaite; Julija Baginskitae; Kieren Egan; Hanna Vesterinen; Gillian L Currie; Leonid Churilov; David W Howells; Emily S Sena
Journal:  PLoS Biol       Date:  2015-10-13       Impact factor: 8.029

8.  A concerted appeal for international cooperation in preclinical stroke research.

Authors:  Ulrich Dirnagl; Antoine Hakim; Malcolm Macleod; Marc Fisher; David Howells; Stuart M Alan; Gary Steinberg; Anna Planas; Johannes Boltze; Sean Savitz; Costantino Iadecola; Stephen Meairs
Journal:  Stroke       Date:  2013-04-18       Impact factor: 7.914

9.  Comparison of two dependent within subject coefficients of variation to evaluate the reproducibility of measurement devices.

Authors:  Mohamed M Shoukri; Dilek Colak; Namik Kaya; Allan Donner
Journal:  BMC Med Res Methodol       Date:  2008-04-22       Impact factor: 4.615

10.  SYRCLE's risk of bias tool for animal studies.

Authors:  Carlijn R Hooijmans; Maroeska M Rovers; Rob B M de Vries; Marlies Leenaars; Merel Ritskes-Hoitinga; Miranda W Langendam
Journal:  BMC Med Res Methodol       Date:  2014-03-26       Impact factor: 4.615

View more
  4 in total

1.  Machine learning based analysis of stroke lesions on mouse tissue sections.

Authors:  Gerasimos Damigos; Evangelia I Zacharaki; Nefeli Zerva; Angelos Pavlopoulos; Konstantina Chatzikyrkou; Argyro Koumenti; Konstantinos Moustakas; Constantinos Pantos; Iordanis Mourouzis; Athanasios Lourbopoulos
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-25       Impact factor: 6.960

2.  Gene Expression Dynamics at the Neurovascular Unit During Early Regeneration After Cerebral Ischemia/Reperfusion Injury in Mice.

Authors:  Roxane-Isabelle Kestner; Franziska Mayser; Rajkumar Vutukuri; Lena Hansen; Stefan Günther; Robert Brunkhorst; Kavi Devraj; Waltraud Pfeilschifter
Journal:  Front Neurosci       Date:  2020-04-02       Impact factor: 4.677

3.  Geranylgeranylacetone attenuates cerebral ischemia-reperfusion injury in rats through the augmentation of HSP 27 phosphorylation: a preliminary study.

Authors:  Kazuya Matsuo; Kohkichi Hosoda; Jun Tanaka; Yusuke Yamamoto; Taichiro Imahori; Tomoaki Nakai; Yasuhiro Irino; Masakazu Shinohara; Takashi Sasayama; Eiji Kohmura
Journal:  BMC Neurosci       Date:  2021-02-08       Impact factor: 3.288

4.  Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke.

Authors:  Sebastian Luger; Annette Schwebler; Rajkumar Vutukuri; Nerea Ferreiros Bouzas; Sandra Labocha; Yannick Schreiber; Robert Brunkhorst; Helmuth Steinmetz; Josef Pfeilschifter; Waltraud Pfeilschifter
Journal:  Ther Adv Neurol Disord       Date:  2018-04-19       Impact factor: 6.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.